NextCell Pharma AB

At a glance

Most recent filing on June 19, 2024 — a sale by Mathias Svahn on Jun 19, 2024.

We hold 2 visible filings, going back to June 18, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 2 shown

This page is free to read, and it stops after 2 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Mathias Svahn Chief executive officer
7,500 SEKOpen-market sale
TradedJun 19, 2024FiledJun 19, 2024
Mathias Svahn Chief executive officer
15,632 SEKOpen-market sale
TradedJun 18, 2024FiledJun 19, 2024